(Q45887660)

17 December 2017

review article

1 reference

title

Gene therapy for nervous system disease (English)

1 reference

17 December 2017

0 references

Tuszynski MH

1

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

17 December 2017

Annals of the New York Academy of Sciences

published in

1 reference

17 December 2017

volume

835

1 reference

17 December 2017

page(s)

1-11

1 reference

17 December 2017

Gene therapy for neurologic disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Gene therapy--a novel form of drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Adenoviruses as gene-delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Nerve growth factor delivery by gene transfer induces differential outgrowth of sensory, motor, and noradrenergic neurites after adult spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Grafting genetically modified cells to the damaged brain: restorative effects of NGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Rescue of basal forebrain cholinergic neurons after implantation of genetically modified cells producing recombinant NGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Grafts of fibroblasts genetically modified to secrete NGF, BDNF, NT-3, or basic FGF elicit differential responses in the adult spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Functional characterization of NGF-secreting cell grafts to the acutely injured spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Gene therapy for human genetic disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Hypophagia is induced by intracerebroventricular administration of nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Blood-brain barrier penetration and in vivo activity of an NGF conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

A comparison of the effects of fornix transection and sulcus principalis ablation upon spatial learning by monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Intrastriatal implants of polymer encapsulated cells genetically modified to secrete human nerve growth factor: trophic effects upon cholinergic and noncholinergic striatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Regional differences in responsiveness of adult CNS axons to grafts of cells expressing human neurotrophin 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Fibroblasts genetically modified to produce nerve growth factor induce robust neuritic ingrowth after grafting to the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

The nerve growth factor 35 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Gene therapeutic approaches to primary and metastatic brain tumors: II. ribozyme-mediated suppression of CD44 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Inducible gene expression systems for higher eukaryotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

Essential role of neocortical acetylcholine in spatial memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1997.TB48613.X

10.1111/J.1749-6632.1997.TB48613.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

9616757

1 reference

17 December 2017